Skip to main content

Featured

CUSMA Wasn’t Renewed: The 10-Year Clock Now Running on Your Job, Prices and Savings

  Canadian Money Brief | Feature CUSMA Wasn't Renewed: The 10-Year Clock Now Running on Your Job, Prices and Savings By MoneySavings.ca | Published November 2, 2026 Quick quiz: is Canada's free trade deal with the United States still in place? The honest answer is yes and no. The agreement known here as CUSMA is still in force, but since July 1 it has been on a different footing, and the way it plays out over the next decade matters to your paycheque, your grocery bill and your savings. Most of us missed the moment because nothing visibly changed that day. That is exactly why it deserves a closer look, especially with the federal budget arriving Thursday. The short version: CUSMA did not end. It moved from a long-term deal to a deal that gets reviewed every year until 2036. Roughly 90% of what Canada sells to the U.S. has been crossing the border tariff-free because of it, so each annual review is a chance for that protection to be tested. For households, this is a slow-burn r...

article

Federal Government Boosts Vaccine Injury Compensation Fund with Additional $36 Million

 

The Canadian federal government has recently allocated an additional $36.4 million to the Vaccine Injury Compensation Fund, a program designed to support individuals who have experienced serious injuries or fatalities related to vaccines since the end of 2020. Here are the key details:

  1. Purpose of the Fund:

    • The program was established shortly after COVID-19 vaccines became available to the public.
    • It provides financial compensation to people who suffered adverse effects due to Health Canada-approved vaccines.
    • The goal is to assist those who were seriously impacted by vaccination.
  2. Funding and Administration:

    • The Liberal government initially earmarked $75 million for the first five years of the program.
    • A private firm called OXARO manages the program and disburses valid claims originating outside of Quebec.
    • To date, OXARO has received $56.2 million from Ottawa and has paid out $11.2 million in compensation.
    • Quebec has its own vaccine injury compensation program, which received $7.75 million when the federal program launched.
  3. Recent Funding Boost:

    • As part of the federal budget, the government allocated an additional $36 million to OXARO and Quebec.
    • This funding covers the next two years of the program.
    • The Public Health Agency of Canada contracted OXARO to ensure an impartial claims process.
  4. Eligibility and Claims:

    • The program covers injuries and deaths associated with vaccines approved for any illness.
    • Eligibility criteria include severe, life-threatening, or life-altering injuries resulting in disability, incapacity, birth defects, or death.
    • The available statistics do not specify which vaccines were involved.
  5. Rare Adverse Reactions:

    • Serious adverse reactions to vaccines are extremely rare (affecting less than one in a million people).
    • Nevertheless, the government recognizes its duty to provide support when such reactions occur.
    • Ottawa has also made COVID-19 vaccination mandatory for travel and federal public service employment.

In summary, the additional funding aims to ensure that those affected by vaccine-related injuries receive appropriate compensation while maintaining an impartial claims process. The program underscores the importance of vaccine safety and accountability in public health efforts. 


Comments